Processing 00000000.tx.1: Degradation of Amylin by Insulin-degrading Enzyme* Robert G. 

Phrase: "Degradation of Amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "by Insulin-degrading Enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "* Robert G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: Bennett, William C. 

Phrase: "Bennett,"

Phrase: "William C."
Processing 00000000.tx.3: Duckworth, and Frederick G. 

Phrase: "Duckworth,"

Phrase: "and"

Phrase: "Frederick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.4: Hamel** From the Medical Research Service, Omaha Veterans Affairs Medical Center and Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68105,the Section of Endocrinology, Carl T.Hayden Veterans Affairs Medical Center, Phoenix, Arizona 85012,the Department of Molecular and Cellular Biology, Arizona State University, Tempe, Arizona 85287,and the **Medical Research Service, Omaha Veterans Affairs Medical Center and Departments of Internal Medicine and Pharmacology, University of Nebraska Medical Center, Omaha, Nebraska 68105 Received for publication, July 12,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES A pathological feature of Type 2diabetes is deposits in the pancreatic islets primarily composed of amylin (islet amyloid polypeptide). 

Phrase: "Hamel"

Phrase: "*"

Phrase: "*"

Phrase: "From the Medical Research Service,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0199168:Medical service [Health Care Activity]
   913   C0587569:medical service [Health Care Activity]
   913   C1546531:Medical Service [Health Care Related Organization]
   827   C0557854:Service [Occupational Activity]
   827   C2825316:Service [Manufactured Object]
   827   C3245478:service [Idea or Concept]
   734   C0079816:Medical Research [Research Activity]
   734   C1556038:Medical Research [Professional or Occupational Group]

Phrase: "Omaha Veterans Affairs Medical Center"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]

Phrase: "and"

Phrase: "Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68105,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]

Phrase: "the Section of Endocrinology,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205155:Section [Spatial Concept]
   770   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   770   C1522472:Section [Substance]
   770   C1552923:Section [Quantitative Concept]
   770   C1705191:Section [Physical Object]

Phrase: "Carl T.Hayden Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   818   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   818   C1549054:Veterans Affairs [Organization]
   818   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   795   C0042610:Veterans [Population Group]
   795   C0205099:Center [Spatial Concept]
   795   C0205476:Medical [Functional Concept]
   762 E C3245459:veteran [Intellectual Product]

Phrase: "Phoenix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331993:Phoenix [Health Care Related Organization]
  1000   C1080696:Phoenix [Plant]

Phrase: "Arizona 85012,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003787:Arizona [Geographic Area]

Phrase: "the Department of Molecular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Cellular Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cellular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Arizona State University,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0003787:Arizona [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Tempe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453232:Tempeh [Food]
  1000   C2718085:TEMPE [Organic Chemical]

Phrase: "Arizona 85287,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003787:Arizona [Geographic Area]

Phrase: "and"

Phrase: "the **Medical Research Service,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0199168:Medical service [Health Care Activity]
   913   C0587569:medical service [Health Care Activity]
   913   C1546531:Medical Service [Health Care Related Organization]
   827   C0557854:Service [Occupational Activity]
   827   C2825316:Service [Manufactured Object]
   827   C3245478:service [Idea or Concept]
   734   C0079816:Medical Research [Research Activity]
   734   C1556038:Medical Research [Professional or Occupational Group]

Phrase: "Omaha Veterans Affairs Medical Center"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]

Phrase: "and"

Phrase: "Departments of Internal Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68105"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "July 12,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A pathological feature of Type 2diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "deposits in the pancreatic islets primarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposits [Functional Concept]

Phrase: "composed of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1415831:AMYLIN [Gene or Genome]

Phrase: "(islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")."
Processing 00000000.tx.5: Although much attention has been paid to the expression and secretion of amylin, little is known about the enzymes involved in amylin turnover. 

Phrase: "Although"

Phrase: "much attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "paid to the expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   737   C0871051:pay [Quantitative Concept]

Phrase: "and"

Phrase: "secretion of amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the enzymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]
   770   C0205309:Known [Qualitative Concept]

Phrase: "involved in amylin turnover."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031227:turnover [Quantitative Concept]
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.6: Recent reports suggest that insulin-degrading enzyme (IDE) may have specificity for amyloidogenic proteins, and therefore we sought to determine whether amylin is an IDE substrate. 

Phrase: "Recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin-degrading enzyme (IDE)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "have"

Phrase: "specificity for amyloidogenic proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "an IDE substrate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0178623:enzyme substrate [Chemical Viewed Functionally]
   812   C1710236:Substrate [Manufactured Object]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.7: Amylin-degrading activity co-purified with IDE from rat muscle through several chromatographic steps. 

Phrase: "Amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "co-purified with IDE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1998793:Purified [Functional Concept]

Phrase: "from rat muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "through several chromatographic steps."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.8: Metalloproteinase inhibitors inactivated amylin-degrading activity with a pattern consistent with the enzymatic properties of IDE, whereas inhibitors of acid and serine proteases, calpains, and the proteasome were ineffective. 

Phrase: "Metalloproteinase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "inactivated"

Phrase: "amylin-degrading activity with a pattern"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "consistent with the enzymatic properties of IDE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "whereas"

Phrase: "inhibitors of acid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "serine proteases,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0036734:serine proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2717971:Serine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "calpains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "were"

Phrase: "ineffective."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242229:ineffective [Idea or Concept]
Processing 00000000.tx.9: Amylin degradation was inhibited by insulin in a dose-dependent manner, whereas insulin degradation was inhibited by amylin. 

Phrase: "Amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "inhibited by insulin"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in a dose-dependent manner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "whereas"

Phrase: "insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "inhibited by amylin."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1415831:AMYLIN [Gene or Genome]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.10: Other substrates of IDE such as atrial natriuretic peptide and glucagon also competitively inhibited amylin degradation. 

Phrase: "Other substrates of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0178623:enzyme substrate [Chemical Viewed Functionally]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "such as atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "glucagon also competitively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "amylin degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.11: Radiolabeled amylin and insulin were both covalently cross-linked to a protein of 110kDa, and the binding was competitively inhibited by either unlabeled insulin or amylin. 

Phrase: "Radiolabeled amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "both covalently"

Phrase: "cross-linked to a protein of 110kDa,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0178576:Cross Linked [Natural Phenomenon or Process]
   778   C0332220:cross linked [Functional Concept]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "competitively"

Phrase: "inhibited by either unlabeled insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.12: Finally, a monoclonal anti-IDE antibody immunoprecipitated both insulin- and amylin-degrading activities. 

Phrase: "Finally,"

Phrase: "a monoclonal anti-IDE antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   885   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   876   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "both insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin-degrading activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.13: The data strongly suggest that IDE is an amylin-degrading enzyme and plays an important role in the clearance of amylin and the prevention of islet amyloid formation.  

Phrase: "The data strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "an amylin-degrading enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the clearance of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "the prevention of islet amyloid formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0199176:Prevention [Therapeutic or Preventive Procedure]
   753   C1706420:PREVENTION [Research Activity]
   753   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES A pathologic feature of as many as 90% of persons with Type 2diabetes is the presence of islet amyloid deposits comprised predominantly of the peptide amylin, also known as islet amyloid polypeptide (reviewed in Ref. 1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A pathologic feature of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1521970:Feature [Qualitative Concept]
   770   C1706388:Feature [Conceptual Entity]
   770   C2346469:Feature [Qualitative Concept]
   770   C2348519:Feature [Qualitative Concept]

Phrase: "as"

Phrase: "many as 90% of persons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0027361:Persons [Population Group]
   760   C0439064:Many [Quantitative Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0747726:many [Conceptual Entity]
   726 E C2347489:Person [Group]

Phrase: "with Type 2diabetes"

Phrase: "is"

Phrase: "the presence of islet amyloid deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "comprised"

Phrase: "predominantly of the peptide amylin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C1415831:AMYLIN [Gene or Genome]

Phrase: "also"

Phrase: "known as islet amyloid polypeptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   862   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0205309:Known [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.15: These deposits are thought to contribute to pancreatic beta cell dysfunction, either by direct cytotoxicity or by reducing beta cell mass (2). 

Phrase: "These deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to pancreatic beta cell dysfunction,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0030281:Pancreatic beta cell [Cell]
           Beta cell
   833   C1969875:Beta-cell dysfunction [Finding]
   753   C0007634:Cell [Cell]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1880177:Contribute [Activity]
   753   C1948049:Cell [Spatial Concept]
   753   C2004068:Beta [Qualitative Concept]

Phrase: "either by direct cytotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439851:Direct [Qualitative Concept]
   770   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   770   C1947931:Direct [Qualitative Concept]

Phrase: "or by reducing beta cell mass"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0030281:Beta cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0330390:Beta [Plant]
   753   C0392756:Reducing [Qualitative Concept]
   753   C0439096:Beta [Intellectual Product]
   753   C0577559:Mass [Finding]
   753   C1269647:Cell [Cell]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2004068:Beta [Qualitative Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Understanding the mechanisms of amyloid formation, and how fibril formation is prevented under normal conditions, is therefore of particular interest in the study of Type 2diabetes. 

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the mechanisms of amyloid formation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "how fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "prevented under normal conditions,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   816   C0231162:Normal condition [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0309872:PREVENT [Pharmacologic Substance]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "therefore of particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "in the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of Type 2diabetes."
Processing 00000000.tx.17: Because amylin is continually produced in non-diabetic humans with no amyloid formation, the mere presence of amylin is not sufficient to cause fibril formation, a concept that has been supported in studies using transgenic mice expressing human amylin (3). 

Phrase: "Because"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "continually"

Phrase: "produced in non-diabetic humans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086418:Humans [Human]
   760   C0241863:DIABETIC [Finding]
   760   C1518422:Non [Functional Concept]

Phrase: "with no amyloid formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "the mere presence of amylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "fibril formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "a concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "supported in studies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0947630:studies [Laboratory Procedure]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: Further studies have suggested that amyloid formation is associated with metabolic perturbations, such as hyperglycemia or high fat intake (4). 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "associated with metabolic perturbations,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0311400:Metabolic [Functional Concept]
   770   C1524026:Metabolic [Cell Function]
   770   C2707259:Metabolic [Clinical Attribute]
   737   C0332453:perturbation [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "such as hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "or"

Phrase: "high fat intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0489488:Fat intake [Clinical Attribute]
   827   C1512806:Intake [Functional Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.19: Therefore, a shift in the amylin balance either by altering synthesis, secretion, or degradation could contribute to amyloid formation. 

Phrase: "Therefore,"

Phrase: "a shift in the amylin balance either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "by altering synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "or"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "could"

Phrase: "contribute to amyloid formation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522492:Formation [Functional Concept]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.20: Although there have been numerous studies regarding amylin synthesis and secretion, at present there have been few studies exploring the degradation of amylin. 

Phrase: "Although"

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "regarding"

Phrase: "amylin synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "at present there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "exploring"

Phrase: "the degradation of amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.21: The levels of proteins are regulated by both synthesis and degradation. 

Phrase: "The levels of proteins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   786   C0428479:Protein level [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "regulated by both synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:synthesis [Biologic Function]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.22: The enzyme responsible for the intracellular degradation of insulin is insulin-degrading enzyme (IDE),1 also known as insulysin (E.C. 3.4.24.56). 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for the intracellular degradation of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "is"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "1 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "known as insulysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0205309:Known [Qualitative Concept]
   790   C1415875:INSULYSIN [Gene or Genome]

Phrase: "(E.C. 3.4.24.56"

Phrase: ")."
Processing 00000000.tx.23: A metallothiolproteinase found primarily in the cytosol, IDE has been detected in lesser amounts in endosomes, peroxisomes, on the plasma membrane, and in an extracellular form (reviewed in Ref. 5). 

Phrase: "A metallothiolproteinase"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "primarily in the cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "detected in lesser amounts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C0547044:Lesser [Qualitative Concept]
   770   C1265611:amounts [Quantitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "peroxisomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "on the plasma membrane,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and in an extracellular form"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C0521119:Extracellular [Cell Component]
   760   C1515981:And [Idea or Concept]
   760   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "reviewed in Ref. 5"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.24: In addition to insulin, a number of other proteins have been identified as IDE substrates, including proteins structurally related to insulin such as proinsulin, insulin-like growth factor II, and relaxin (6), and seemingly unrelated peptides, such as atrial natriuretic peptide (ANP) and glucagon (7, 8). 

Phrase: "In addition to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a number of other proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified as IDE substrates,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   773   C0178623:enzyme substrate [Chemical Viewed Functionally]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205396:Identified [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "proteins structurally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "related to insulin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0163712:Relate [Organic Chemical]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "such as proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "insulin-like growth factor II,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "relaxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035031:Relaxin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "seemingly unrelated peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "such as atrial natriuretic peptide (ANP)"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.25: However, insulin, ANP, and glucagon all contain regions that can form beta-pleated sheets, and thus are amyloid-forming peptides (9). 

Phrase: "However,"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "ANP,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "all"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "beta-pleated sheets,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C0599215:Beta Pleated Sheet [Cell Component]
           Beta Sheet
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0439643:Sheets [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   793 E C2349187:Sheet [Quantitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "are"

Phrase: "amyloid-forming peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.26: Thus, it has been proposed that, rather than displaying specificity for a primary sequence motif, IDE is specific for amyloidogenic peptides (8, 10). 

Phrase: "Thus,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that,"

Phrase: "rather than"

Phrase: "displaying specificity for a primary sequence motif,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "specific for amyloidogenic peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "(8,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.27: Indeed, recently the Alzheimer's -amyloid peptide was shown to be degraded by IDE, and IDE was implicated in regulating extracellular levels of -amyloid peptide (11-13). 

Phrase: "Indeed,"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the Alzheimer's -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "degraded by IDE,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1881707:DEGRADED [Phenomenon or Process]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "implicated in"

Phrase: "regulating"

Phrase: "extracellular levels of -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(11-13"

Phrase: ")."
Processing 00000000.tx.28: Therefore, because amylin is an amyloid-forming peptide, it may also be a substrate for IDE. 

Phrase: "Therefore,"

Phrase: "because"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "an amyloid-forming peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "it"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "a substrate for IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0178623:enzyme substrate [Chemical Viewed Functionally]
   753   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.29: The studies presented here characterize an amylin-degrading activity purified from rat muscle and identify the degrading enzyme as IDE.  

Phrase: "The studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "characterize"

Phrase: "an amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "purified from rat muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026845:Muscle [Tissue]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "identify"

Phrase: "the degrading enzyme as IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
Processing 00000000.tx.30: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Human and rat amylin were from Bachem. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "were from Bachem."
Processing 00000000.tx.31: 125I-Human amylin was from Peninsula Laboratories. 

Phrase: "125I-Human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "was from Peninsula Laboratories."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.32: In all cases, human amylin was diluted with deionized water from stock solutions immediately before use to minimize the spontaneous formation of amyloid fibrils. 

Phrase: "In all cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "diluted with deionized water"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "from stock solutions immediately before"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0037633:Solutions [Substance]
   812   C0205548:Immediately [Temporal Concept]
   812   C1710198:Stock [Idea or Concept]
   779 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "the spontaneous formation of amyloid fibrils."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   809   C3544412:amyloid fibril formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.33: Because of variable amounts of contaminating 125I-labeled bovine serum albumin, in some cases 125I-amylin was purified by reverse-phase HPLC as described below. 

Phrase: "Because of variable amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of contaminating 125I-labeled bovine serum albumin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   827   C0728877:serum albumin [Laboratory or Test Result]
   799   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0007452:Bovine [Mammal]
   799   C0229671:Serum [Body Substance]
   799   C1140701:bovine [Mammal]
   799   C1546774:Serum [Intellectual Product]
   799   C1550100:Serum [Body Substance]

Phrase: "in some cases 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "purified by reverse-phase HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1555029:Reverse [Idea or Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "as"

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.34: Biosynthetic human insulin and 125I-insulin (labeled on the A14 position) were generously provided by Ronald Chance and Bruce Frank, respectively, of Lilly Research Laboratories. 

Phrase: "Biosynthetic human insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0220781:Biosynthetic [Biologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "labeled on the A14 position"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0733755:Position [Spatial Concept]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: "were"

Phrase: "generously"

Phrase: "provided by Ronald Chance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237506:Chance [Qualitative Concept]
   770   C1999230:Provided [Activity]

Phrase: "and"

Phrase: "Bruce Frank,"

Phrase: "respectively,"

Phrase: "of Lilly Research Laboratories."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   867   C0022886:research laboratory [Research Activity]
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.35: The covalent cross-linking reagent NHS-ASA was from Pierce. 

Phrase: "The covalent cross-linking reagent NHS-ASA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0001128:Acid [Chemical]
   791   C0202406:Acid [Laboratory Procedure]

Phrase: "was from Pierce."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.36: All chemicals were reagent grade or better. 

Phrase: "All chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "reagent grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441800:Grade [Classification]
   861   C0919553:Grade [Classification]
   861   C3244287:grade [Finding]

Phrase: "or"

Phrase: "better."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]
Processing 00000000.tx.37: Rat Skeletal Muscle IDE Purification-- Homogenates of hind leg muscle from 100-to 120-g male Harlan Sprague-Dawley rats were prepared and purified by 30-60% ammonium sulfate precipitation and batchwise DEAE-Sephacel purification as described previously (14). 

Phrase: "Rat Skeletal Muscle IDE Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0243114:purification [Functional Concept]
   795   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "Homogenates of hind leg muscle"

Phrase: "from 100-"

Phrase: "to 120-g male Harlan Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0034715:Rats, Sprague-Dawley [Mammal]
   818   C2699239:Sprague-Dawley [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "purified by 30-60% ammonium sulfate precipitation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   748   C0002611:Ammonium [Inorganic Chemical]
   748   C0032931:Precipitation [Natural Phenomenon or Process]
   748   C0032932:Precipitation [Molecular Function]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C1642401:% precipitation [Quantitative Concept]
   748   C1998793:Purified [Functional Concept]
   748   C2584299:Precipitation [Natural Phenomenon or Process]
   748   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "batchwise DEAE-Sephacel purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243114:purification [Functional Concept]
   812   C1998793:Purification [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.38: The preparation was further purified by chromatography on DEAE-Sephacel, pentyl agarose, and chromatofocusing columns as described (15), except that dithiothreitol was omitted from the buffers and a Mono-P fast-protein liquid chromatography column was used as the chromatofocusing matrix. 

Phrase: "The preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified by chromatography"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008550:Chromatography [Laboratory Procedure]
   790   C1998793:Purified [Functional Concept]

Phrase: "on DEAE-Sephacel,"

Phrase: "pentyl agarose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Agarose [Carbohydrate]

Phrase: "and"

Phrase: "chromatofocusing columns as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1185738:Column [Body Part, Organ, or Organ Component]
   737   C1706132:Column [Idea or Concept]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "omitted from the buffers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0750563:omitted [Idea or Concept]

Phrase: "and"

Phrase: "a Mono-P fast-protein liquid chromatography column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0684296:Chromatography.column [Laboratory Procedure]
   795   C1185738:Column [Body Part, Organ, or Organ Component]
   795   C1706132:Column [Idea or Concept]
   710   C0599209:Fast Protein Liquid Chromatography [Laboratory Procedure]

Phrase: "was"

Phrase: "used as the chromatofocusing matrix."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C1273517:used [Finding]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.39: After concentration of the chromatofocusing peak using a microconcentrator with a 10-kDa cutoff (Centriprep-10, Amicon), the sample was applied to a Bio-Gel A-0.5m (Bio-Rad) gel filtration column (1.584cm) equilibrated with 50mM HEPES, 0.15M NaCl, pH 7.4.

Phrase: "After concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the chromatofocusing peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microconcentrator with a 10-kDa cutoff"

Phrase: "(Centriprep-10,"

Phrase: "Amicon"

Phrase: ")"

Phrase: ","

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "applied to a Bio-Gel A-0.5m"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0185125:Applied [Health Care Activity]
   744   C1382104:Gel [Substance]
   711 E C1632850:Apply [Functional Concept]
   711 E C1879355:Apply [Functional Concept]

Phrase: "(Bio-Rad) gel filtration column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "(1.584cm"

Phrase: ")"

Phrase: "equilibrated with 50mM HEPES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0450400:50mm [Quantitative Concept]

Phrase: "0.15M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.40: The peak of insulin-degrading activity was pooled and stored in aliquots at 70C until used. 

Phrase: "The peak of insulin-degrading activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:Peak [Quantitative Concept]

Phrase: "was"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "stored in aliquots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1510844:Aliquot [Quantitative Concept]
   756   C1698986:Store [Functional Concept]

Phrase: "at 70C"

Phrase: "until"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.41: Protein was determined by the bicinchoninic acid assay (Pierce). 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "determined by the bicinchoninic acid assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.42: Measurement of Amylin- and Insulin-degrading Activities-- The degradation of insulin and amylin were measured by the trichloroacetic acid solubility assay. 

Phrase: "Measurement of Amylin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "Insulin-degrading Activities"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   896   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441655:Activities [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "were"

Phrase: "measured by the trichloroacetic acid solubility assay."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0037628:Solubility [Qualitative Concept]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.43: All studies were performed in test tubes coated with bovine serum albumin to prevent adsorption of the substrates. 

Phrase: "All studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed in test tubes"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0183884:test tubes [Medical Device]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0175730:tubes [Medical Device]
   770   C0392366:test [Intellectual Product]
   770   C0884358:Performed [Functional Concept]
   770   C1547937:Tubes [Intellectual Product]
   770   C1704474:Tubes [Quantitative Concept]
   737 E C1561954:tube [Conceptual Entity]
   737 E C1704730:TUBE [Medical Device]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "coated with bovine serum albumin to"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1522408:Coated [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "adsorption of the substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001674:Adsorption [Laboratory Procedure]
Processing 00000000.tx.44: An appropriate amount of enzyme was incubated with tracer 125I-insulin or 125I-amylin in 100mM Tris, pH 7.5,for 15min at 37C (reaction volume 0.5ml). 

Phrase: "An appropriate amount of enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with tracer 125I-insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522485:Tracer [Indicator, Reagent, or Diagnostic Aid]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "125I-amylin in 100mM Tris,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C1415831:AMYLIN [Gene or Genome]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 15min"

Phrase: "at 37C"

Phrase: "(reaction volume 0.5ml"

Phrase: ")."
Processing 00000000.tx.45: The reaction was terminated by adding 25l of 10% bovine serum albumin and 125l of 50% trichloroacetic acid. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by adding 25l of 10% bovine serum albumin"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   764   C0728877:serum albumin [Laboratory or Test Result]
   762 E C0523465:Albumin - serum [Laboratory Procedure]
   742   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007452:Bovine [Mammal]
   742   C0229671:Serum [Body Substance]
   742   C1140701:bovine [Mammal]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1553404:terminated [Idea or Concept]
   742   C2348570:Terminated [Functional Concept]
   708   C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "125l of 50% trichloroacetic acid."
Processing 00000000.tx.46: After chilling in an ice bath for 15min, the tubes were centrifuged at 3000g for 15min, and the radioactivity in the supernatants and pellets was counted. 

Phrase: "After chilling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085593:chilling [Sign or Symptom]

Phrase: "in an ice bath"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150141:Bath [Therapeutic or Preventive Procedure]

Phrase: "for 15min,"

Phrase: "the tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "centrifuged at 3000g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 15min,"

Phrase: "and"

Phrase: "the radioactivity in the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.47: The degree of degradation is expressed as the percentage of trichloroacetic acid-soluble counts. 

Phrase: "The degree of degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "is"

Phrase: "expressed as the percentage of trichloroacetic acid-soluble counts."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   764   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0439157:counts [Quantitative Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1749467:soluble [Cell Component]
   742   C1948047:Soluble [Qualitative Concept]
   708 E C0750480:Count [Activity]
   708 E C1705566:Count [Quantitative Concept]
Processing 00000000.tx.48: Reverse-phase HPLC Analysis-- Samples of intact and degraded 125I-amylin were applied to a Supelcosil ODS column (Supelco) equilibrated in 0.1% trifluoroacetic acid in water (Buffer A). 

Phrase: "Reverse-phase HPLC Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C2986798:Phase Analysis [Occupational Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Samples of intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "degraded 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "were"

Phrase: "applied to a Supelcosil ODS column (Supelco)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0185125:Applied [Health Care Activity]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "equilibrated in 0.1% trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "(Buffer A"

Phrase: ")."
Processing 00000000.tx.49: The samples were eluted using a linear gradient of 0-60% 0.1% trifluoroacetic acid in acetonitrile (Buffer B) over 45min, followed by 60-100% B over 15min. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "eluted"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a linear gradient of 0-60% 0.1% trifluoroacetic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0439182:% gradient [Quantitative Concept]
   739   C0812409:Gradient [Quantitative Concept]

Phrase: "in acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "(Buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "B) over 45min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "followed by 60-100% B"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0332283:Followed by [Temporal Concept]
           followed
   726 E C1719822:Follow [Intellectual Product]

Phrase: "over 15min."
Processing 00000000.tx.50: Fractions of 1ml were collected, and the radioactivity was measured. 

Phrase: "Fractions of 1ml"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   866   C1264633:Fraction of [Quantitative Concept]
           Fractions
   756 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.51: Covalent Cross-linking-- Partially purified IDE was covalently cross-linked to either 125I-amylin or 125I-insulin using the heterobifunctional amine/photoactive cross-linker N-hydroxysuccinimidyl-4-azidosalicylic acid (NHS-ASA). 

Phrase: "Covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "--"

Phrase: "Partially purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "covalently"

Phrase: "cross-linked to either 125I-amylin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0178576:Cross Linked [Natural Phenomenon or Process]
   790   C0332220:cross linked [Functional Concept]
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1415831:AMYLIN [Gene or Genome]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "or"

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the heterobifunctional amine/photoactive cross-linker N-hydroxysuccinimidyl-4-azidosalicylic acid (NHS-ASA)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001128:Acid [Chemical]
   790   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.52: In a total volume of 50l, IDE, purified through the ammonium sulfate precipitation step as above (0.3mg of protein), was incubated with approximately 50,000cpm of either 125I-insulin or HPLC-purified 125I-amylin. 

Phrase: "In a total volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0449468:Total Volume [Quantitative Concept]
           *Volume
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 50l,"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "purified through the ammonium sulfate precipitation step"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   748   C0002611:Ammonium [Inorganic Chemical]
   748   C0032931:Precipitation [Natural Phenomenon or Process]
   748   C0032932:Precipitation [Molecular Function]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C1261552:Step [Conceptual Entity]
   748   C1642401:% precipitation [Quantitative Concept]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C1998793:Purified [Functional Concept]
   748   C2584299:Precipitation [Natural Phenomenon or Process]
   748   C2825408:Step [Manufactured Object]
   748   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "(0.3mg of protein"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "incubated with approximately 50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332232:Approximately [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "000cpm of either 125I-insulin"

Phrase: "or"

Phrase: "HPLC-purified 125I-amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   812   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.53: To determine the specificity of cross-linking, excess (0.1mg/ml) unlabeled amylin or insulin was included in some samples. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the specificity of"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0037791:Specificity [Quantitative Concept]
   790   C1511884:Specificity [Quantitative Concept]
   718 E C0205369:Specific [Qualitative Concept]
   718 E C1552740:specific [Intellectual Product]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: ","

Phrase: "excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979886:Excess [Qualitative Concept]

Phrase: "(0.1mg/ml) unlabeled amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   804   C1415831:AMYLIN [Gene or Genome]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "included in some samples."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737   C0370003:Sample [Substance]
   737 E C1552866:include [Idea or Concept]
   737   C2347026:Sample [Conceptual Entity]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.54: After 30min on ice, the samples received NHS-ASA to 1mM (or Me2SO vehicle alone) under darkroom conditions, and the samples were incubated on ice for 20min in the dark, then 20min under UV light. 

Phrase: "After 30min"

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "NHS-ASA to 1mM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "("

Phrase: "or"

Phrase: "Me2SO vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0042444:Vehicle [Biomedical or Dental Material]
   861   C0348005:Vehicle [Manufactured Object]
   789 E C0445373:Vehicular [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ")"

Phrase: "under darkroom conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20min"

Phrase: "in the dark,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "then 20min under UV light."
Processing 00000000.tx.55: The samples were diluted in 50l of 2 SDS-PAGE sample buffer, resolved on 7.5% SDS-PAGE, dried, and visualized by Phosphor-Imager (Molecular Dynamics) analysis. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted in 50l of 2 SDS-PAGE sample buffer,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   762   C1538567:PAGE-2 [Gene or Genome]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0370003:Sample [Substance]
   742   C1704732:Page [Intellectual Product]
   742   C2347026:Sample [Conceptual Entity]
   708   C1720119:Dilute [Functional Concept]
   708   C1948037:Dilute [Functional Concept]

Phrase: "resolved on 7.5% SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   783   C1538570:PAGE-5 [Gene or Genome]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704732:Page [Intellectual Product]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "visualized by Phosphor-Imager"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234621:Visualized [Functional Concept]
   770   C0259980:phosphor [Chemical Viewed Functionally]
   770   C1708466:Imager [Manufactured Object]

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")"

Phrase: "analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]
Processing 00000000.tx.56: Immunodepletion Studies-- Purified IDE was incubated with the monoclonal anti-IDE antibody 9B12 (kindly provided by Richard A.Roth, Stanford University) at various concentrations overnight at 4C. 

Phrase: "Immunodepletion Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "--"

Phrase: "Purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with the monoclonal anti-IDE antibody 9B12"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   777   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0746619:monoclonal [Finding]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(kindly"

Phrase: "provided by Richard A.Roth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999230:Provided [Activity]

Phrase: "Stanford University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "at various concentrations overnight"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.57: For control experiments, IDE was incubated with mouse anti-tubulin antibody (Sigma). 

Phrase: "For control experiments,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with mouse anti-tubulin antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C2937342:tubulin [Cell Component]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.58: The antibodies were precipitated with Protein A-Sepharose (Amersham Pharmacia Biotech) coated with goat anti-mouse IgG (Jackson Immunochemicals) for 2h at 4C, then the samples were centrifuged at 10,000g for 15min. 

Phrase: "The antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "precipitated with Protein A-Sepharose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0075172:protein A-sepharose [Carbohydrate]
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   726   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "coated with goat anti-mouse IgG (Jackson Immunochemicals"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   767   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0018019:goat [Mammal]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C1265549:goat [Mammal]
   744   C1510458:Goat [Mammal]
   744   C1522408:Coated [Qualitative Concept]
   711 E C0453946:Coat [Manufactured Object]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 15min."
Processing 00000000.tx.59: The supernatants were removed and assayed for residual amylin- and insulin-degrading activities as above.  

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "assayed for residual amylin-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C1609982:Residual [Qualitative Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "insulin-degrading activities as above."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   781   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0441655:Activities [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.60: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Purification of IDE was carried out by sequential purification from rat skeletal muscle by a modification of chromatographic methods described previously (14, 15). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Purification of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by sequential purification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243114:purification [Functional Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "from rat skeletal muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "by a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of chromatographic methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.61: Amylin-degrading activity purified through all steps with IDE, and the specific activity increased throughout the procedure (Table I), resulting in a 180-fold enrichment of amylin degradation. 

Phrase: "Amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "purified through all steps"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1261552:steps [Conceptual Entity]
   770   C1998793:Purified [Functional Concept]
   737 E C1704379:Step [Functional Concept]
   737 E C1705117:Step [Quantitative Concept]
   737 E C2825408:Step [Manufactured Object]

Phrase: "with IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1552740:specific [Intellectual Product]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "increased throughout the procedure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1948041:Procedure [Therapeutic or Preventive Procedure]
   770   C2700391:Procedure [Activity]
   770   C3274430:PROCEDURE [Health Care Activity]
   770   C3538935:Procedure [Idea or Concept]
   770   C3539779:Procedure [Intellectual Product]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "resulting in a 180-fold enrichment of amylin degradation."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0332294:Resulting in [Functional Concept]
   742   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   742   C0243125:degradation [Functional Concept]
   742   C0332462:Fold [Spatial Concept]
   742   C0678226:resulting [Functional Concept]
   742   C0699900:Degradation [Organism Function]
   742   C1415831:AMYLIN [Gene or Genome]
   742   C1880834:FOLD [Phenomenon or Process]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]
Processing 00000000.tx.62: For comparison, insulin-degrading activity was purified 140-fold in the same series (not shown). 

Phrase: "For comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "140-fold in the same series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.63: To further characterize this activity, 125I-amylin degradation was measured in the presence of increasing doses of unlabeled amylin or insulin (Fig. 1). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "this activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "125I-amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "measured in the presence of increasing doses of unlabeled amylin"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   739   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   739   C0178602:Doses [Quantitative Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0442808:Increasing [Functional Concept]
   739   C0444706:Measured [Qualitative Concept]
   739   C1415831:AMYLIN [Gene or Genome]
   739   C3541902:MEASURED [Diagnostic Procedure]
   706 E C0079809:Measure [Quantitative Concept]
   706 E C0242485:Measure [Functional Concept]
   706 E C0869039:Dose [Quantitative Concept]
   706 E C1114758:Dose # [Clinical Attribute]
   706 E C1428722:DOS [Gene or Genome]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.64: Both amylin and insulin reduced 125I-amylin degradation in a dose-dependent manner (IC50 290and 80nM, respectively). 

Phrase: "Both amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "125I-amylin degradation in a dose-dependent manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "(IC50 290and 80nM,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.65: Similarly, when 125I-insulin degradation was measured (Fig. 2), both competitor amylin and insulin decreased 125I-insulin degradation (IC50 160and 27nM, respectively) with a similar profile to that in Fig. 

Phrase: "Similarly,"

Phrase: "when"

Phrase: "125I-insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "both competitor amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "125I-insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "(IC50 160and 27nM,"

Phrase: "respectively"

Phrase: ")"

Phrase: "with a similar profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "to that"

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.66: 1, strongly suggesting that the same enzyme is responsible for degrading both amylin and insulin. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the same enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "responsible for degrading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "both amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.67: To verify that the acid-soluble radioactivity was due to amylin degradation, 125I-amylin was incubated with purified IDE for 0or 30min, then analyzed by reverse-phase C18 chromatography (Fig. 3). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that"

Phrase: "the acid-soluble radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was due to amylin degradation,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0043194:WAS [Disease or Syndrome]
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C0243125:degradation [Functional Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0699900:Degradation [Organism Function]
   760   C1415831:AMYLIN [Gene or Genome]
   760   C1421478:WAS [Gene or Genome]
   760   C3146286:Due [Idea or Concept]

Phrase: "125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "incubated with purified IDE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1998793:Purified [Functional Concept]

Phrase: "for 0or 30min,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by reverse-phase C18 chromatography"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1555029:Reverse [Idea or Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.68: Intact amylin eluted at ~41 min. 

Phrase: "Intact amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "eluted"

Phrase: "at ~41 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.69: After degradation by IDE, the disappearance of the amylin peak at 41min was accompanied by the accumulation of three degradation products eluting at approximately 26,31,and 35min. 

Phrase: "After degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "by IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the disappearance of the amylin peak"

Phrase: "at 41min"

Phrase: "was"

Phrase: "accompanied by the accumulation of three degradation products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0205449:Three [Quantitative Concept]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "eluting at approximately 26,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332232:Approximately [Qualitative Concept]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "and"

Phrase: "35min."
Processing 00000000.tx.70: When the peak areas were quantified, the degree of degradation measured by HPLC was similar to that estimated by trichloroacetic acid in the same sample (~30% degraded). 

Phrase: "When"

Phrase: "the peak areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "were"

Phrase: "quantified"

Phrase: ","

Phrase: "the degree of degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "measured by HPLC"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "estimated by trichloroacetic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0750572:Estimated [Quantitative Concept]

Phrase: "in the same sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "(~30% degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881707:DEGRADED [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.71: In general, there was linear agreement between the two methods within the range of degradation tested (0-40%).  

Phrase: "In general, there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205246:General [Spatial Concept]
   861   C1553889:General [Idea or Concept]

Phrase: "was"

Phrase: "linear agreement between the two methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680240:Agreement [Social Behavior]

Phrase: "within the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(0-40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.72: View this table: [in this window] [in a new window]  Table I Purification of amylin-degrading activity View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Purification of amylin-degrading activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243114:purification [Functional Concept]
   748   C1998793:Purification [Functional Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.73: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.74: Amylin degradation is inhibited by excess insulin or amylin. 

Phrase: "Amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "inhibited by excess insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1979886:Excess [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.75: The effect of increasing doses of unlabeled human insulin (closed symbols) or amylin (open symbols) on the degradation of 125I-amylin was determined. 

Phrase: "The effect of increasing doses of unlabeled human insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "(open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "on the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.76: The data are expressed as the percentage of degradation in the absence of unlabeled hormone (meanS.E., for three independent experiments). 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the percentage of degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243125:degradation [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of unlabeled hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(meanS.E.,"

Phrase: "for three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.77: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.78: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.79: Insulin degradation is inhibited by excess insulin or amylin. 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "inhibited by excess insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1979886:Excess [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.80: The effect of increasing doses of unlabeled human insulin (closed symbols) or amylin (open symbols) on the degradation of 125I-insulin was determined. 

Phrase: "The effect of increasing doses of unlabeled human insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "(open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "on the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of 125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.81: The data are expressed as the percentage of degradation in the absence of unlabeled hormone (meanS.E., for three independent experiments). 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the percentage of degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243125:degradation [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of unlabeled hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(meanS.E.,"

Phrase: "for three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.82: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.83: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.84: HPLC analysis of amylin degradation products. 

Phrase: "HPLC analysis of amylin degradation products."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.85: Degradation products of amylin were generated by incubation of 125I-amylin without (top) and with (bottom) purified IDE and then analyzed by reverse-phase HPLC as described under "Experimental Procedures." 

Phrase: "Degradation products of amylin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0063684:Amylin product [Amino Acid, Peptide, or Protein,Hormone]
   770   C1514468:Products [Entity]
   737 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "generated by incubation of 125I-amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1415831:AMYLIN [Gene or Genome]
   753   C3146294:Generated [Activity]

Phrase: "without"

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by reverse-phase HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.86: The data are expressed as the percentage of the total recovered radioactivity for each experiment. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the percentage of the total recovered radioactivity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0034553:Radioactivity [Natural Phenomenon or Process]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0521108:recovered [Qualitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   708 E C2004454:recover [Organism Function]

Phrase: "for each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.87: To determine whether the amylin-degrading activity is due to IDE, a panel of inhibitors was used to characterize the enzymatic properties of the amylin-degrading activity (Table II). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is due to IDE,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3146286:Due [Idea or Concept]

Phrase: "a panel of inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441833:Panel [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the enzymatic properties of the amylin-degrading activity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.88: The activity was greatly inhibited by N-ethylmaleimide, 1,10-phenanthroline, and bacitracin and inhibited to a lesser degree by EDTA and EGTA, consistent with the metallothiolproteinase characteristics of IDE. 

Phrase: "The activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "greatly"

Phrase: "inhibited by N-ethylmaleimide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0311403:Inhibited [Qualitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "and"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "and"

Phrase: "inhibited to a lesser degree"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0311403:Inhibited [Qualitative Concept]
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C0547044:Lesser [Qualitative Concept]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "by EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "consistent with the metallothiolproteinase characteristics of IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.89: Conversely, other cysteine proteinase inhibitors (E-64, leupeptin), inhibitors of acid proteases (pepstatin), serine proteases (aprotinin, leupeptin, PMSF) and calpains (ALLN), were ineffective at inhibiting amylin degradation. 

Phrase: "Conversely,"

Phrase: "other cysteine proteinase inhibitors"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0010658:Cysteine Proteinase Inhibitors [Biologically Active Substance,Pharmacologic Substance]
  1000   C2756981:Cysteine Proteinase Inhibitors [Molecular Function]
   901   C2717970:Cysteine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   867   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   867   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   867   C2673177:proteinase inhibitor [Molecular Function]
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(E-64,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "inhibitors of acid proteases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   786 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "serine proteases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0036734:serine proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2717971:Serine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "(aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "PMSF"

Phrase: ")"

Phrase: "and"

Phrase: "calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(ALLN"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "ineffective at inhibiting amylin degradation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3242229:ineffective [Idea or Concept]
Processing 00000000.tx.90: In addition, because ALLN at 1mM is a potent proteasome inhibitor, degradation of amylin by the proteasome in this preparation can be ruled out. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "because"

Phrase: "ALLN at 1mM"

Phrase: "is"

Phrase: "a potent proteasome inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   901   C2266856:Proteasome Inhibitor [Molecular Function]
   901   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "degradation of amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "by the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "in this preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.91: Taken together, the amylin-degrading enzyme has the properties of a neutral metallothiolproteinase, and the inhibition profile is consistent with the enzymatic properties of IDE.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the amylin-degrading enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "the properties of a neutral metallothiolproteinase,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "the inhibition profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "consistent with the enzymatic properties of IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.92: View this table: [in this window] [in a new window]  Table II Inhibitors of IDE inhibit amylin-degrading activity The degradation of 125I-amylin by purified IDE was measured in the absence and presence of protease inhibitors at the indicated concentrations. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Inhibitors of IDE"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   774   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   774   C0021643:inhibitors insulin [Pharmacologic Substance]
   774   C1152555:enzyme inhibitors [Molecular Function]
   774   C2756995:Enzyme Inhibitors [Molecular Function]
   757 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "The degradation of 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in the absence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "presence of protease inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at the indicated concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.93: The data are expressed as percentage of inhibition of amylin-degrading activity in the absence of inhibitor. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percentage of inhibition of amylin-degrading activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   742   C0205177:Activity [Functional Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1415831:AMYLIN [Gene or Genome]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.94: Because IDE degrades other proteins in addition to insulin, the ability of these substrates to competitively inhibit amylin degradation was examined (Table III). 

Phrase: "Because"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degrades"

Phrase: "other proteins in addition to insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the ability of these substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "to competitively"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Table III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.95: The IDE substrates insulin, glucagon, ANP, and ACTH all effectively inhibited the amylin-degrading activity. 

Phrase: "The IDE substrates insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "ANP,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ACTH"

Phrase: "all effectively"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the amylin-degrading activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.96: In addition to human amylin, rat amylin also inhibited human amylin degradation. 

Phrase: "In addition to human amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "rat amylin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "human amylin degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
Processing 00000000.tx.97: In contrast, EGF, which binds IDE but with low affinity, had little effect, and insulin C-peptide, which is not a IDE substrate, had no effect. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "EGF,"

Phrase: "which"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but with low affinity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205251:low [Qualitative Concept]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C1299352:Low [Qualitative Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1550472:low [Idea or Concept]

Phrase: "had"

Phrase: "little effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin C-peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a IDE substrate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0178623:enzyme substrate [Chemical Viewed Functionally]
   812   C1710236:Substrate [Manufactured Object]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "had"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.98: Taken together, these data demonstrate that the amylin-degrading activity is consistent with the enzymatic characteristics of IDE.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "consistent with the enzymatic characteristics of IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.99: View this table: [in this window] [in a new window]  Table III Amylin degradation is competitively inhibited by IDE substrates The degradation of 125I-amylin by purified IDE was measured in the absence and presence of the indicated peptides (all at 100nM). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table III Amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "competitively"

Phrase: "inhibited by IDE substrates"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   773   C0178623:enzyme substrate [Chemical Viewed Functionally]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "The degradation of 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in the absence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "presence of the indicated peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "all at 100nM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.100: The data are expressed as percentage of inhibition of amylin-degrading activity in the absence of additional peptide. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percentage of inhibition of amylin-degrading activity"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   742   C0205177:Activity [Functional Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1415831:AMYLIN [Gene or Genome]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of additional peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.101: To examine amylin-binding proteins in the IDE preparation, covalent cross-linking experiments were performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "amylin-binding proteins in the IDE preparation,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1149286:enzyme binding [Molecular Function]
   762   C1623517:insulin binding [Molecular Function]
   745 E C0033618:Protein Binding [Molecular Function]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.102: Early experiments using traditional cross-linking reagents such as the homobifunctional amine-reactive disuccinimidyl suberate were unsuccessful when using amylin as the substrate. 

Phrase: "Early experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "traditional cross-linking reagents such as the homobifunctional amine-reactive disuccinimidyl suberate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0010360:Cross-Linking Reagents [Indicator, Reagent, or Diagnostic Aid]
   753   C0332220:Cross-linking [Functional Concept]
   751   C0010357:Cross-reactive [Molecular Function]
   736   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   736 E C0178576:Cross link [Natural Phenomenon or Process]
   736   C2828360:Cross [Conceptual Entity]
   703   C1517892:Link [Intellectual Product]
   703   C1704666:Link [Intellectual Product]

Phrase: "were"

Phrase: "unsuccessful"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1272705:Unsuccessful [Qualitative Concept]

Phrase: "when"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "amylin as the substrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.103: This may have been due to the lack of reactive groups on the amylin molecule, which contains a single amino acid with primary amines (the N-terminal lysine). 

Phrase: "This"

Phrase: "may"

Phrase: "have"

Phrase: "been due to the lack of reactive groups"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0205332:Reactive [Qualitative Concept]
   744   C0332268:lack [Qualitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1552839:groups [Idea or Concept]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C3146286:Due [Idea or Concept]

Phrase: "on the amylin molecule,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a single amino acid with primary amines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0682967:primary aminoacid [Amino Acid, Peptide, or Protein]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "("

Phrase: "the N-terminal lysine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.104: Therefore, a heterobifunctional amine/photoreactive reagent (NHS-ASA) was used. 

Phrase: "Therefore,"

Phrase: "a heterobifunctional amine/photoreactive reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(NHS-ASA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.105: Partially purified IDE (through the ammonium sulfate precipitation step) was incubated with either 125I-amylin or 125I-insulin, and associated proteins were cross-linked with NHS-ASA (Fig. 4). 

Phrase: "Partially purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "through the ammonium sulfate precipitation step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "incubated with either 125I-amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C1415831:AMYLIN [Gene or Genome]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "125I-insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "associated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "cross-linked with NHS-ASA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0178576:Cross Linked [Natural Phenomenon or Process]
   770   C0332220:cross linked [Functional Concept]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C2828360:Cross [Conceptual Entity]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.106: In the absence of NHS-ASA (Me2SO only), no cross-linking of labeled amylin or insulin was detected. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of NHS-ASA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "(Me2SO only"

Phrase: ")"

Phrase: ","

Phrase: "no"

Phrase: "cross-linking of labeled amylin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C1415831:AMYLIN [Gene or Genome]
   760   C1708632:Labeled [Qualitative Concept]
   760   C2828360:Cross [Conceptual Entity]
   726 E C0181496:Label [Manufactured Object]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.107: In the presence of NHS-ASA, a radiolabeled band at approximately 110kDa was readily detected using either 125I-amylin or 125I-insulin. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of NHS-ASA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "a radiolabeled band at approximately 110kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "readily"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "or"

Phrase: "125I-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.108: This is consistent with amylin binding by IDE, which migrates on SDS-PAGE at 110kDa. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with amylin binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "which"

Phrase: "migrates on SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0232902:migrate [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "at 110kDa."
Processing 00000000.tx.109: In the presence of either excess insulin or amylin, the cross-linking to the 110-kDa protein was abolished, indicating the specificity of the binding. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of either excess insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "the"

Phrase: "cross-linking to the 110-kDa protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332220:Cross-linking [Functional Concept]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   757   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1532717:kDa [Quantitative Concept]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "abolished"

Phrase: ","

Phrase: "indicating"

Phrase: "the specificity of the binding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.110: No other specifically cross-linked proteins were detected. 

Phrase: "No"

Phrase: "other specifically"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.111: These data show that a protein at 110kDa on SDS-PAGE binds both insulin and amylin and is consistent with amylin degradation by IDE. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a protein at 110kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "consistent with amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.112: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 4.  

Phrase: "4."
Processing 00000000.tx.114: Covalent cross-linking of 125I-amylin. 

Phrase: "Covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking of 125I-amylin."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   760   C1415831:AMYLIN [Gene or Genome]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.115: Partially purified IDE was incubated with 125I-amylin for 30min, then the covalent cross-linking reagent NHS-ASA was used to analyze amylin binding proteins. 

Phrase: "Partially purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with 125I-amylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30min,"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the covalent cross-linking reagent NHS-ASA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0001128:Acid [Chemical]
   791   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "amylin binding proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.116: The samples were resolved on 7.5% SDS-PAGE, and radioactivity was detected by phosphorimaging analysis. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "resolved on 7.5% SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   783   C1538570:PAGE-5 [Gene or Genome]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704732:Page [Intellectual Product]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "detected by phosphorimaging analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.117: To definitively establish IDE as the protease responsible for amylin degradation in this preparation, immunodepletion studies were performed. 

Phrase: "To definitively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "IDE as the protease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
           Insulin Protease
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "responsible for amylin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in this preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "immunodepletion studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.118: Purified IDE was incubated with the monoclonal IDE-specific antibody 9B12 at various concentrations, then the antibody was precipitated with anti-mouse IgG-coated Protein A-Sepharose. 

Phrase: "Purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with the monoclonal IDE-specific antibody 9B12"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0021644:Insulin antibody [Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205369:Specific [Qualitative Concept]
   739   C0746619:monoclonal [Finding]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1552740:specific [Intellectual Product]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "at various concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "precipitated with anti-mouse IgG-coated Protein A-Sepharose."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0075172:protein A-sepharose [Carbohydrate]
   764   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0063422:IgG-sepharose [Carbohydrate]
   762   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1423498:coat-protein [Gene or Genome]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036681:Sepharose [Carbohydrate]
   742   C1522408:Coated [Qualitative Concept]
   708 E C0453946:Coat [Manufactured Object]
   708   C1882443:PRECIPITATE [Phenomenon or Process]
   708 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.119: The precipitates were removed, and the supernatants were measured for residual amylin- and insulin-degrading activities (Fig. 5). 

Phrase: "The precipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "measured for residual amylin-"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0444706:Measured [Qualitative Concept]
   770   C1415831:AMYLIN [Gene or Genome]
   770   C1609982:Residual [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "insulin-degrading activities"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   896   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441655:Activities [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.120: The removal of IDE with increasing antibody concentration correlated with a loss of both amylin- and insulin-degrading activity. 

Phrase: "The removal of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "with increasing antibody concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "correlated with a loss of both amylin-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   748   C1415831:AMYLIN [Gene or Genome]
   748   C1517945:Loss [Quantitative Concept]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-degrading activity."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.121: In contrast, an isotype-matched control antibody (anti-tubulin), even at concentrations as high as 25g/ml, did not affect either degrading activity. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "an isotype-matched control antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "even at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "as 25g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "either degrading activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.122: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.124: An anti-IDE antibody immunodepletes both insulin- and amylin-degrading activities. 

Phrase: "An anti-IDE antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "immunodepletes"

Phrase: "both insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin-degrading activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.125: Purified IDE was incubated with the indicated concentration of either the monoclonal IDE-specific antibody 9B12 (closed symbols) or a control isotype-matched antibody specific for -tubulin (open symbols). 

Phrase: "Purified IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with the indicated concentration of either"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0086045:Concentration [Mental Process]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1444656:Indicated [Finding]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "the monoclonal IDE-specific antibody 9B12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(closed symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "a control isotype-matched antibody specific for -tubulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0021017:Antibody Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]

Phrase: "(open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: The antibodies were precipitated with anti-mouse IgG-coated Protein A-Sepharose, and the residual 125I-amylin (squares) or 125I-insulin (circles) degrading activities were determined. 

Phrase: "The antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "precipitated with anti-mouse IgG-coated Protein A-Sepharose,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0075172:protein A-sepharose [Carbohydrate]
   764   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0063422:IgG-sepharose [Carbohydrate]
   762   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1423498:coat-protein [Gene or Genome]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036681:Sepharose [Carbohydrate]
   742   C1522408:Coated [Qualitative Concept]
   708 E C0453946:Coat [Manufactured Object]
   708   C1882443:PRECIPITATE [Phenomenon or Process]
   708 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the residual 125I-amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "(squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205120:Square [Spatial Concept]
   966   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "degrading activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.127: The data are expressed as the percentage of degradation in the absence of antibody (meanS.E., for three independent experiments).  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the percentage of degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243125:degradation [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(meanS.E.,"

Phrase: "for three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.128: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The formation of amyloid deposits is a critical event in the pathogenesis of many diseases, including Alzheimer's disease and Type 2diabetes. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The formation of amyloid deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "a critical event in the pathogenesis of many diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0441471:Event [Event]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Type 2diabetes."
Processing 00000000.tx.129: Much of the research performed to date has focused on the expression of the amyloid-forming proteins. 

Phrase: "Much of the research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]

Phrase: "performed to date"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011008:Date [Temporal Concept]
   790   C0884358:Performed [Functional Concept]
   790   C2348077:Date [Food]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "has"

Phrase: "focused on the expression of the amyloid-forming proteins."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   762   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   745   C1171362:expression protein [Genetic Function]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205234:Focused [Spatial Concept]
   742   C0205431:Forming [Functional Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1285542:focused [Functional Concept]
   742   C1522492:Forming [Functional Concept]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0376315:Form [Manufactured Object]
Processing 00000000.tx.130: Little is known about the processes responsible for the turnover and clearance of amyloid-forming proteins. 

Phrase: "Little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205309:Known [Qualitative Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "responsible for the turnover"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "clearance of amyloid-forming proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.131: Recently, IDE was implicated in the degradation of the Alzheimer's disease beta-amyloid peptide (11, 12). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "implicated in the degradation of the Alzheimer's disease beta-amyloid peptide"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   770   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   756   C2825879:Amyloid, Beta [Laboratory Procedure]
   754   C0002726:amyloid disease [Disease or Syndrome]
   754   C1523817:peptide degradation [Molecular Function]
   754 E C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   738   C0243125:degradation [Functional Concept]
   738   C0330390:Beta [Plant]
   738   C0439096:Beta [Intellectual Product]
   738   C0699900:Degradation [Organism Function]
   738   C2004068:Beta [Qualitative Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.132: Further studies have suggested that IDE plays a role in the control of extracellular levels of Alzheimer's beta-amyloid peptide (13, 16). 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the control of extracellular levels of Alzheimer's beta-amyloid peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0035820:Role [Social Behavior]
   735   C1705810:Role [Conceptual Entity]

Phrase: "(13,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.133: Therefore, there is emerging evidence that a major role of IDE may be in the clearance of amyloid-forming peptides. 

Phrase: "Therefore,"

Phrase: "there"

Phrase: "is"

Phrase: "emerging"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "a major role of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "may"

Phrase: "be in the clearance of amyloid-forming peptides."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0205431:Forming [Functional Concept]
   744   C0449297:Clearance [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1382187:Clearance [Clinical Attribute]
   744   C1522492:Forming [Functional Concept]
   744   C2825073:Clearance [Natural Phenomenon or Process]
   744   C2987476:Be [Conceptual Entity]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
Processing 00000000.tx.134: Amylin is co-produced and co-packaged with insulin by pancreatic beta cells. 

Phrase: "Amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "co-produced"

Phrase: "and"

Phrase: "co-"

Phrase: "packaged with insulin"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0030176:packaged [Human-caused Phenomenon or Process]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0013194:Package [Medical Device]
   756 E C2700580:Package [Manufactured Object]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by pancreatic beta cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: In as many as 90% of persons with Type 2diabetes, amyloid plaques are found in the area of the beta cells, and contribute to beta cell dysfunction and death. 

Phrase: "In"

Phrase: "as"

Phrase: "many as 90% of persons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0027361:Persons [Population Group]
   760   C0439064:Many [Quantitative Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0747726:many [Conceptual Entity]
   726 E C2347489:Person [Group]

Phrase: "with Type 2diabetes,"

Phrase: "amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "found in the area of the beta cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   744   C0007634:Cells [Cell]
   744   C0017446:Area [Geographic Area]
   744   C0150312:Found [Quantitative Concept]
   744   C0205146:Area [Spatial Concept]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C2004068:Beta [Qualitative Concept]
   744   C3282337:Cells [Cell]
   737   C0030281:Beta cell [Cell]
   711 E C0243095:Find [Finding]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "contribute to beta cell dysfunction"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C1969875:Beta-cell dysfunction [Finding]
   806   C0030281:Beta cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1880177:Contribute [Activity]
   760   C1948049:Cell [Spatial Concept]
   760   C2004068:Beta [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.136: The studies presented here identify IDE as an amylin-degrading enzyme. 

Phrase: "The studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "identify"

Phrase: "IDE as an amylin-degrading enzyme."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.137: In a typical series of purification steps used to isolate IDE, amylin-degrading activity co-purified with insulin-degrading activity through all steps. 

Phrase: "In a typical series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "of purification steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "co-purified with insulin-degrading activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1998793:Purified [Functional Concept]

Phrase: "through all steps."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261552:steps [Conceptual Entity]
   966 E C1704379:Step [Functional Concept]
   966 E C1705117:Step [Quantitative Concept]
   966 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.138: The insulin-degrading activity was inhibited by amylin in a dose-dependent manner, whereas amylin-degrading activity was similarly inhibited by excess insulin, suggesting that both insulin and amylin are degraded by the same protease in the preparation. 

Phrase: "The insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "inhibited by amylin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1415831:AMYLIN [Gene or Genome]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "in a dose-dependent manner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "whereas"

Phrase: "amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "similarly"

Phrase: "inhibited by excess insulin,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1979886:Excess [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "are"

Phrase: "degraded by the same protease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0445247:Same [Qualitative Concept]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C1947941:Protease [Enzyme]

Phrase: "in the preparation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.139: The inhibitor profile identifies the enzyme as a metallothiolproteinase with properties consistent with those reported previously for IDE. 

Phrase: "The inhibitor profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "identifies"

Phrase: "the enzyme as a metallothiolproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "with properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "consistent with those reported previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.140: On the other hand, the amylin-degrading activity was not inhibited by serine or acid protease inhibitors nor by an inhibitor of calpains and proteasomes. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the amylin-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by serine"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "or"

Phrase: "acid protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "nor by an inhibitor of calpains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0028423:NOR [Geographic Area]
   753   C0028609:NOR [Cell Component]
   753   C1513854:NOR [Mammal]
   753   C1999216:Inhibitor [Qualitative Concept]
   719   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "proteasomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325620:proteasome [Cell Component]
   966 E C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.141: The amylin-degrading proteinase had affinity for insulin, glucagon, ACTH, and ANP, but not for EGF or insulin C-peptide, all consistent with the specificity of IDE. 

Phrase: "The amylin-degrading proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]

Phrase: "had"

Phrase: "affinity for insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "ACTH,"

Phrase: "and"

Phrase: "ANP,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "not for EGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "insulin C-peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "all consistent with the specificity of IDE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.142: Using a cross-linking reagent, the association of a 110-kDa protein with radiolabeled amylin was detected. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cross-linking reagent,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0332220:Cross-linking [Functional Concept]
   884 E C0178576:Cross link [Natural Phenomenon or Process]
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   827   C2828360:Cross [Conceptual Entity]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]

Phrase: "the association of a 110-kDa protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with radiolabeled amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "was"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.143: This cross-linking was abolished in the presence of either excess insulin or amylin, indicating that the same protein binds both amylin and insulin. 

Phrase: "This"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "abolished in the presence of either excess insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1979886:Excess [Qualitative Concept]

Phrase: "or"

Phrase: "amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "indicating"

Phrase: "that"

Phrase: "the same protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "both amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.144: This finding was supported by the observation that radiolabeled insulin cross-linked to the 110-kDa protein was also eliminated with excess insulin or amylin, strongly suggesting that the 110-kDa insulin and amylin binding protein is IDE. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that radiolabeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cross-linked to the 110-kDa protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0178576:Cross Linked [Natural Phenomenon or Process]
   778   C0332220:cross linked [Functional Concept]
   774   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1532717:kDa [Quantitative Concept]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "also"

Phrase: "eliminated with excess insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0849355:Eliminated [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1979886:Excess [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the 110-kDa insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.145: Finally, a well-characterized monoclonal antibody directed against IDE co-immunodepleted both insulin- and amylin-degrading activity, providing definitive evidence that IDE is the amylin-degrading proteinase. 

Phrase: "Finally,"

Phrase: "a well-characterized monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "directed against IDE co-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "immunodepleted"

Phrase: "both insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin-degrading activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "definitive evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the amylin-degrading proteinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.146: Because IDE is an amylin-degrading enzyme, it may play an important role in amylin homeostasis. 

Phrase: "Because"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "an amylin-degrading enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "it"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in amylin homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.147: It is important to remember that in species expressing amyloidogenic amylin (including humans), amylin is continually present, yet does not normally aggregate into amyloid deposits. 

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "remember"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679062:remember [Mental Process]

Phrase: "that in species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705920:Species [Conceptual Entity]

Phrase: "expressing"

Phrase: "amyloidogenic amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: ")"

Phrase: ","

Phrase: "amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "is"

Phrase: "continually"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: ","

Phrase: "yet"

Phrase: "does"

Phrase: "not normally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "aggregate into amyloid deposits."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2936349:Amyloid Deposits [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0205418:Aggregate [Qualitative Concept]
   770   C0333562:Deposits [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.148: Therefore, the mere presence of amylin does not predicate islet amyloid formation. 

Phrase: "Therefore,"

Phrase: "the mere presence of amylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "predicate"

Phrase: "islet amyloid formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.149: This has been explored further in studies using transgenic animals. 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "explored"

Phrase: "further in studies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0947630:studies [Laboratory Procedure]
   790   C1517331:Further [Spatial Concept]
   756 E C0205108:far [Spatial Concept]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transgenic animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]
Processing 00000000.tx.150: Although some lines of transgenic mice overexpressing human amylin displayed amyloid deposits (17, 18), others did not (3, 19-21), suggesting that elevated amylin alone may not be sufficient for amyloid formation. 

Phrase: "Although"

Phrase: "some lines of transgenic mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")"

Phrase: ","

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "did"

Phrase: "not (3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "19-21"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that elevated amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "sufficient for amyloid formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.151: Therefore, a perturbation of some other element of amylin processing, such as amylin degradation, may be involved. 

Phrase: "Therefore,"

Phrase: "a perturbation of some"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:perturbation [Functional Concept]

Phrase: "other element of amylin processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0013879:Element [Element, Ion, or Isotope]
   760   C1705248:Element [Conceptual Entity]

Phrase: "such as amylin degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "be"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.152: Amylin from a number of species, including human, spontaneously aggregates into amyloid fibrils as a result of -pleated sheet formation around residues 20-29 of the primary sequence. 

Phrase: "Amylin from a number of species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   753   C1415831:AMYLIN [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "human,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "spontaneously"

Phrase: "aggregates into amyloid fibrils"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0205418:Aggregate [Qualitative Concept]
   770   C0225328:fibrils [Cell Component]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C1948066:Fibril [Physical Object]

Phrase: "as a result of -pleated sheet formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "around residues 20-29"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "of the primary sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.153: Rodent amylin, on the other hand, does not form amyloid, presumably because proline residues in this area of the molecule alter secondary structure (22). 

Phrase: "Rodent amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "presumably"

Phrase: "because"

Phrase: "proline residues in this area of the molecule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.154: In the studies presented here, IDE degraded both human and rat amylin. 

Phrase: "In the studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here,"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "both human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.155: It would follow that the recognition motif for IDE is not the -pleated sheet region itself, but the structure of the peptides in the non-amyloid-forming state. 

Phrase: "It"

Phrase: "would"

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "that"

Phrase: "the recognition motif for IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the -pleated sheet region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "itself,"

Phrase: "but"

Phrase: "the structure of the peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0597196:peptide structure [Spatial Concept]
   760   C0678594:Structure [Spatial Concept]

Phrase: "in the non-amyloid-forming state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
Processing 00000000.tx.156: Indeed, most if not all studies of IDE and insulin have been performed under conditions in which insulin does not spontaneously form amyloid fibrils. 

Phrase: "Indeed,"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "if"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all"

Phrase: "studies of IDE"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2603343:Study [Research Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "performed under conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0884358:Performed [Functional Concept]
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   756 E C2947996:Perform [Pharmacologic Substance]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "in which insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not spontaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid fibrils."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.157: The role of IDE may, therefore, be in the cleavage of peptides with the potential to form amyloid aggregates. 

Phrase: "The role of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "may"

Phrase: ","

Phrase: "therefore,"

Phrase: "be in the cleavage of peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010813:cleavage [Cell Function]
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C2987476:Be [Conceptual Entity]

Phrase: "with the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.158: In this case, IDE can be thought of as a scavenger of amyloidogenic peptides. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "thought of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0039869:Thought [Mental Process]

Phrase: "as"

Phrase: "a scavenger of amyloidogenic peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017108:scavenger [Medical Device]
   760   C1003377:scavenger [Fish]
Processing 00000000.tx.159: Normally, a balance exists between deposition and degradation of the amyloidogenic peptide. 

Phrase: "Normally,"

Phrase: "a balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "exists between deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0333562:Deposition [Functional Concept]
   790   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "degradation of the amyloidogenic peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1523817:peptide degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.160: When the levels of the peptide exceed the capacity of IDE to degrade them, either by increased expression of the peptide, or decreased expression or enzymatic activity of IDE, the balance is shifted from degradation to deposition. 

Phrase: "When"

Phrase: "the levels of the peptide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "exceed"

Phrase: "the capacity of IDE to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "degrade"

Phrase: "them,"

Phrase: "either by increased expression of the peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: "or"

Phrase: "decreased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "enzymatic activity of IDE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2267219:Enzymatic Activity [Molecular Function]
   783   C0243102:enzyme activity [Molecular Function]
   783   C1145751:insulin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "the balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "is"

Phrase: "shifted from degradation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243125:degradation [Functional Concept]
   790   C0333051:shifted [Functional Concept]
   790   C0699900:Degradation [Organism Function]
   756 E C2347509:Shift [Phenomenon or Process]

Phrase: "to deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.161: In the case of Type 2diabetes, both insulin and amylin secretion are increased due to peripheral insulin resistance. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of Type 2diabetes,"

Phrase: "both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "amylin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "are"

Phrase: "increased due to peripheral insulin resistance."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C0678226:Due to [Functional Concept]
           due
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   783   C0020459:increased insulin [Disease or Syndrome]
   783   C1258192:Peripheral Resistance [Physiologic Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205100:Peripheral [Spatial Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0237834:Resistance [Mental Process]
   753   C0442805:Increased [Functional Concept]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3146286:Due [Idea or Concept]
   748   C0332325:Resistant to [Functional Concept]
Processing 00000000.tx.162: Because IDE has approximately 4-fold greater affinity for insulin than for amylin, amylin degradation will be proportionately impaired. 

Phrase: "Because"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "approximately 4-fold greater affinity for insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "than"

Phrase: "for amylin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "amylin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "will"

Phrase: "be"

Phrase: "proportionately"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.163: The increased production and relative decrease in degradation may allow sufficient accumulation of amylin to cause islet amyloid formation. 

Phrase: "The increased production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "relative decrease in degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "may"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "sufficient accumulation of amylin to"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "islet amyloid formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.164: The site of both synthesis of amylin and deposition of islet amyloid, the pancreatic beta cells, is a logical site of amylin degradation. 

Phrase: "The site of both synthesis of amylin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "deposition of islet amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011560:Amyloid deposition [Pathologic Function]
   819   C1705760:Amyloid Deposition [Finding]
   770   C0333562:Deposition [Functional Concept]

Phrase: "the pancreatic beta cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a logical site of amylin degradation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.165: An insulin-degrading enzyme consistent with the properties of IDE has been reported in islets and in a beta cell line (23). 

Phrase: "An insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "consistent with the properties of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "has"

Phrase: "been"

Phrase: "reported in islets"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and in a beta cell line"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0007600:Cell Line [Cell]
   790   C0030281:Beta cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2004068:Beta [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.166: Furthermore, recent studies in our laboratory have suggested that IDE is responsible for amylin degradation in a beta cell line and that inhibition of IDE increases the formation of amyloid by exogenous human amylin (24). 

Phrase: "Furthermore,"

Phrase: "recent studies in our laboratory"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0681827:Laboratory studies [Laboratory Procedure]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "responsible for amylin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in a beta cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0007600:Cell Line [Cell]
   861   C0030281:Beta cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that inhibition of IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0877008:enzyme inhibition [Disease or Syndrome]
   783   C1524081:Enzyme Inhibition [Physiologic Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the formation of amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "by exogenous human amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   827   C1415831:AMYLIN [Gene or Genome]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.167: If this proves to be the case, then IDE would be a critical player in the prevention of amyloid formation by amylin and perhaps other amyloidogenic peptides. 

Phrase: "If"

Phrase: "this"

Phrase: "proves"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "would"

Phrase: "be"

Phrase: "a critical player in the prevention of amyloid formation"

Phrase: "by amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: "and"

Phrase: "perhaps"

Phrase: "other amyloidogenic peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.168: A new area of study focusing on turnover of amyloidogenic peptides could lead to novel therapeutic approaches in the treatment of amyloid diseases.  

Phrase: "A new area of study focusing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]

Phrase: "on turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031227:turnover [Quantitative Concept]
  1000   C0243127:turnover [Functional Concept]
  1000   C0443331:Turnover [Health Care Activity]

Phrase: "of amyloidogenic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "could"

Phrase: "lead to novel therapeutic approaches"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0205314:Novel [Temporal Concept]
   760   C0302350:Therapeutic [Functional Concept]
   760   C0449445:Approaches [Spatial Concept]
   760   C0679622:novel [Intellectual Product]
   760   C1292724:Approaches [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of amyloid diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002726:amyloid diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.169: FOOTNOTES * This work was funded in part by the Department of Veterans Affairs Research Service and in part by the Bly Memorial Research Fund, University of Nebraska Medical Center.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "funded in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016820:funded [Quantitative Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the Department of Veterans Affairs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   861   C1549054:Veterans Affairs [Organization]
   812   C0042610:Veterans [Population Group]
   812   C1704729:Department [Organization]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557854:Service [Occupational Activity]
  1000   C2825316:Service [Manufactured Object]
  1000   C3245478:service [Idea or Concept]

Phrase: "and in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1515981:And [Idea or Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the Bly Memorial Research Fund,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]

Phrase: "University of Nebraska Medical Center."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
Processing 00000000.tx.170: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.171: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.172: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.173: To whom correspondence should be addressed: Medical Research Service (151), Veterans Affairs Medical Ctr., 4101Woolworth Ave., Omaha, NE 68105.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Medical Research Service"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0199168:Medical service [Health Care Activity]
   913   C0587569:medical service [Health Care Activity]
   913   C1546531:Medical Service [Health Care Related Organization]
   827   C0557854:Service [Occupational Activity]
   827   C2825316:Service [Manufactured Object]
   827   C3245478:service [Idea or Concept]
   734   C0079816:Medical Research [Research Activity]
   734   C1556038:Medical Research [Professional or Occupational Group]

Phrase: "(151"

Phrase: ")"

Phrase: ","

Phrase: "Veterans Affairs Medical Ctr.,"

Phrase: "4101Woolworth Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "NE 68105.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.174: 402-346-8800ext. 

Phrase: "402-346-8800ext."
Processing 00000000.tx.175: 3105; 

Phrase: "3105"

Phrase: ";"
Processing 00000000.tx.176: Fax: 402-449-0604; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "402-449-0604"

Phrase: ";"
Processing 00000000.tx.177: E-mail: rgbennet@unmc.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "rgbennet@unmc.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.178: Published, JBC Papers in Press, September 5,2000,DOI 10.1074/jbc.M006170200  ABBREVIATIONS The abbreviations used are: IDE, insulin-degrading enzyme; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "September 5,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M006170200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.179: ANP, atrial natriuretic peptide; 

Phrase: "ANP,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.180: NHS-ASA, N-hydroxysuccinimidyl-4-azidosalicylic acid; 

Phrase: "NHS-ASA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "N-hydroxysuccinimidyl-4-azidosalicylic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.181: E-64, trans-epoxysucciny-L-leucylamido-(4-guanidino)butane; 

Phrase: "E-64,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058882:E 64 [Organic Chemical,Pharmacologic Substance]

Phrase: "trans-epoxysucciny-L-leucylamido-"

Phrase: "(4-guanidino"

Phrase: ")"

Phrase: "butane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006474:Butane [Organic Chemical,Pharmacologic Substance]
  1000   C0006476:butane [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.182: PMSF, phenylmethylsulfonyl fluoride; 

Phrase: "PMSF,"

Phrase: "phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.183: ALLN, N-acetyl-Leu-Leu-norleucinal; 

Phrase: "ALLN,"

Phrase: "N-acetyl-Leu-Leu-norleucinal"

Phrase: ";"
Processing 00000000.tx.184: ACTH, adrenocorticotropic hormone; 

Phrase: "ACTH,"

Phrase: "adrenocorticotropic hormone"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0001655:Adrenocorticotrophic Hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C1523997:Adrenocorticotropic Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C2825093:Adrenocorticotropic Hormone [Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.185: EGF, epidermal growth factor; 

Phrase: "EGF,"

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: ";"
Processing 00000000.tx.186: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.187: HPLC, high pressure liquid chromatography.  

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high pressure liquid chromatography."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0460139:Pressure [Finding]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1306345:Pressure [Functional Concept]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.188: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.189: Kahn, S. 

Phrase: "Kahn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.190: E., Andrikopoulos, S., and Verchere, C. 

Phrase: "E.,"

Phrase: "Andrikopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Verchere,"

Phrase: "C."
Processing 00000000.tx.191: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.192: (1999) Diabetes 48, 241-253[Abstract/Free FullText] 2. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "241-253"

Phrase: "[Abstract/Free FullText"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.193: Johnson, K. 

Phrase: "Johnson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.194: H., O'Brien, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "O'Brien,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.195: D., Betsholtz, C., and Westermark, P. 

Phrase: "D."

Phrase: ","

Phrase: "Betsholtz,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Westermark,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.196: (1989) N. 

Phrase: "(1989"

Phrase: ")"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.197: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.198: J.Med. 

Phrase: "J.Med."
Processing 00000000.tx.199: 321, 513-518[Abstract] 3. 

Phrase: "321,"

Phrase: "513-518"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.200: Verchere, C. 

Phrase: "Verchere,"

Phrase: "C."
Processing 00000000.tx.201: B., D'Alessio, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D'"

Phrase: "Alessio,"

Phrase: "D."
Processing 00000000.tx.202: A., Wang, S., Andrikopoulos, S., and Kahn, S. 

Phrase: "A.,"

Phrase: "Wang,"

Phrase: "S."

Phrase: ","

Phrase: "Andrikopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kahn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.203: E. 

Phrase: "E."
Processing 00000000.tx.204: (1997) Horm. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Horm."
Processing 00000000.tx.205: Metab. 

Phrase: "Metab."
Processing 00000000.tx.206: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.207: 29, 311-316[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "29,"

Phrase: "311-316"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.208: Verchere, C. 

Phrase: "Verchere,"

Phrase: "C."
Processing 00000000.tx.209: B., D'Alessio, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D'"

Phrase: "Alessio,"

Phrase: "D."
Processing 00000000.tx.210: A., Palmiter, R. 

Phrase: "A.,"

Phrase: "Palmiter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.211: D., Weir, G. 

Phrase: "D."

Phrase: ","

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.212: C., Bonner-Weir, S., Baskin, D. 

Phrase: "C., Bonner-Weir,"

Phrase: "S."

Phrase: ","

Phrase: "Baskin,"

Phrase: "D."
Processing 00000000.tx.213: G., and Kahn, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Kahn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.214: E. 

Phrase: "E."
Processing 00000000.tx.215: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.216: Natl. 

Phrase: "Natl."
Processing 00000000.tx.217: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.218: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.219: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.220: 93, 3492-3496[Abstract/Free FullText] 5. 

Phrase: "93,"

Phrase: "3492-3496"

Phrase: "[Abstract/Free FullText"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.221: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.222: C., Bennett, R. 

Phrase: "C., Bennett,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.223: G., and Hamel, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hamel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.224: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.225: (1998) Endocr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.226: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.227: 19, 608-624[Abstract/Free FullText] 6. 

Phrase: "19,"

Phrase: "608-624"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.228: Roth, R. 

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.229: A., Mesirow, M. 

Phrase: "A.,"

Phrase: "Mesirow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.230: L., Yokono, K., and Baba, S. 

Phrase: "L., Yokono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Baba,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.231: (1984) Endocr. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.232: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.233: 10, 101[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "10,"

Phrase: "101"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.234: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.235: C., and Kitabchi, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Kitabchi,"

Phrase: "A."
Processing 00000000.tx.236: E. 

Phrase: "E."
Processing 00000000.tx.237: (1974) Diabetes 23, 536-543[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Diabetes 23,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0450348:23 [Quantitative Concept]

Phrase: "536-543"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.238: Muller, D., Baumeister, H., Buck, F., and Richter, D. 

Phrase: "Muller,"

Phrase: "D."

Phrase: ","

Phrase: "Baumeister,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Buck,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0852885:buck [Injury or Poisoning]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Richter,"

Phrase: "D."
Processing 00000000.tx.239: (1991) Eur. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.240: J.

Phrase: "J."
Processing 00000000.tx.241: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.242: 202, 285-292[Abstract] 9. 

Phrase: "202,"

Phrase: "285-292"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 9."
Processing 00000000.tx.243: Sipe, J. 

Phrase: "Sipe,"

Phrase: "J."
Processing 00000000.tx.244: D. 

Phrase: "D."
Processing 00000000.tx.245: (1992) Annu. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.246: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.247: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.248: 61, 947-975[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "61,"

Phrase: "947-975"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.249: Kurochkin, I. 

Phrase: "Kurochkin,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.250: V. 

Phrase: "V."
Processing 00000000.tx.251: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.252: 427, 153-156[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "427,"

Phrase: "153-156"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.253: Goto, S., and Kurochkin, I. 

Phrase: "Goto,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kurochkin,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.254: V. 

Phrase: "V."
Processing 00000000.tx.255: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.256: 345, 33-37[CrossRef][Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "345,"

Phrase: "33-37"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.257: McDermott, J. 

Phrase: "McDermott,"

Phrase: "J."
Processing 00000000.tx.258: R., and Gibson, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Gibson,"

Phrase: "A."
Processing 00000000.tx.259: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.260: (1997) Neurochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.261: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.262: 22, 49-56[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "22,"

Phrase: "49-56"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.263: Qiu, W. 

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.264: Q., Walsh, D. 

Phrase: "Q., Walsh,"

Phrase: "D."
Processing 00000000.tx.265: M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. 

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.266: B., Rosner, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.267: R., Safavi, A., Hersh, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Safavi,"

Phrase: "A.,"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.268: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.269: J. 

Phrase: "J."
Processing 00000000.tx.270: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.271: Biol. 

Phrase: "Biol."
Processing 00000000.tx.272: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.273: 273, 32730-32738[Abstract/Free FullText] 14. 

Phrase: "273,"

Phrase: "32730-32738"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.274: Duckworth, W. 

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.275: C., Heinemann, M., and Kitabchi, A. 

Phrase: "C., Heinemann,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kitabchi,"

Phrase: "A."
Processing 00000000.tx.276: E. 

Phrase: "E."
Processing 00000000.tx.277: (1972) Proc. 

Phrase: "(1972"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.278: Natl. 

Phrase: "Natl."
Processing 00000000.tx.279: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.280: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.281: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.282: 69, 3698-3702[Abstract] 15. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "3698-3702"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15."
Processing 00000000.tx.283: Shii, K., Yokono, K., Baba, S., and Roth, R. 

Phrase: "Shii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yokono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Baba,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.284: A. 

Phrase: "A."
Processing 00000000.tx.285: (1986) Diabetes 35, 675-683[Abstract] 16. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Diabetes 35,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "675-683"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 16."
Processing 00000000.tx.286: Vekrellis, K., Ye, Z., Qiu, W. 

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.287: Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. 

Phrase: "Q., Walsh,"

Phrase: "D."

Phrase: ","

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."

Phrase: ","

Phrase: "Chesneau,"

Phrase: "V.,"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.288: R., and Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.289: J. 

Phrase: "J."
Processing 00000000.tx.290: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.291: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.292: 20, 1657-1665[Abstract/Free FullText] 17. 

Phrase: "20,"

Phrase: "1657-1665"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.293: Yagui, K., Yamaguchi, T., Kanatsuka, A., Shimada, F., Huang, C. 

Phrase: "Yagui,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yamaguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kanatsuka,"

Phrase: "A.,"

Phrase: "Shimada,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Huang,"

Phrase: "C."
Processing 00000000.tx.294: I., Tokuyama, Y., Ohsawa, H., Yamamura, K., Miyazaki, J., Mikata, A., Yoshida, S., and Makino, H. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tokuyama,"

Phrase: "Y.,"

Phrase: "Ohsawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Miyazaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]

Phrase: "J.,"

Phrase: "Mikata,"

Phrase: "A.,"

Phrase: "Yoshida,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Makino,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.295: (1995) Eur. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.296: J.

Phrase: "J."
Processing 00000000.tx.297: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.298: 132, 487-496[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "132,"

Phrase: "487-496"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.299: Janson, J., Soeller, W. 

Phrase: "Janson,"

Phrase: "J.,"

Phrase: "Soeller,"

Phrase: "W."
Processing 00000000.tx.300: C., Roche, P. 

Phrase: "C., Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331965:Roche [Health Care Related Organization]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.301: C., Nelson, R. 

Phrase: "C., Nelson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.302: T., Torchia, A. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Torchia,"

Phrase: "A."
Processing 00000000.tx.303: J., Kreutter, D. 

Phrase: "J.,"

Phrase: "Kreutter,"

Phrase: "D."
Processing 00000000.tx.304: K., and Butler, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Butler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402644:Butler [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.305: C. 

Phrase: "C."
Processing 00000000.tx.306: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.307: Natl. 

Phrase: "Natl."
Processing 00000000.tx.308: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.309: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.310: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.311: 93, 7283-7288[Abstract/Free FullText] 19. 

Phrase: "93,"

Phrase: "7283-7288"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.312: Hoppener, J. 

Phrase: "Hoppener,"

Phrase: "J."
Processing 00000000.tx.313: W., Verbeek, J. 

Phrase: "W., Verbeek,"

Phrase: "J."
Processing 00000000.tx.314: S., de Koning, E. 

Phrase: "S."

Phrase: ","

Phrase: "de Koning,"

Phrase: "E."
Processing 00000000.tx.315: J., Oosterwijk, C., van Hulst, K. 

Phrase: "J.,"

Phrase: "Oosterwijk,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "van Hulst,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.316: L., Visser-Vernooy, H. 

Phrase: "L., Visser-Vernooy,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.317: J., Hofhuis, F. 

Phrase: "J.,"

Phrase: "Hofhuis,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.318: M., van Gaalen, S., Berends, M. 

Phrase: "M."

Phrase: ","

Phrase: "van Gaalen,"

Phrase: "S."

Phrase: ","

Phrase: "Berends,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.319: J., Hackeng, W. 

Phrase: "J.,"

Phrase: "Hackeng,"

Phrase: "W."
Processing 00000000.tx.320: H., Jansz, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jansz,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.321: S., Morris, J. 

Phrase: "S."

Phrase: ","

Phrase: "Morris,"

Phrase: "J."
Processing 00000000.tx.322: F., Clark, A., Capel, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "A.,"

Phrase: "Capel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.323: J., and Lips, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lips,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023759:LIPS [Body Part, Organ, or Organ Component]
   966 E C1278911:Lip [Body Part, Organ, or Organ Component]
   900 E C0227759:Labia [Body Part, Organ, or Organ Component]
   900 E C1070701:Labia [Eukaryote]
   900 E C2626732:Labium [Eukaryote]

Phrase: "C."
Processing 00000000.tx.324: J. 

Phrase: "J."
Processing 00000000.tx.325: (1993) Diabetologia 36, 1258-1265[Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Diabetologia 36,"

Phrase: "1258-1265"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.326: Fox, N., Schrementi, J., Nishi, M., Ohagi, S., Chan, S. 

Phrase: "Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016633:Fox [Mammal]
   928 E C0049564:FOXY [Organic Chemical]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Schrementi,"

Phrase: "J.,"

Phrase: "Nishi,"

Phrase: "M."

Phrase: ","

Phrase: "Ohagi,"

Phrase: "S."

Phrase: ","

Phrase: "Chan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.327: J., Heisserman, J. 

Phrase: "J.,"

Phrase: "Heisserman,"

Phrase: "J."
Processing 00000000.tx.328: A., Westermark, G. 

Phrase: "A.,"

Phrase: "Westermark,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.329: T., Leckstrom, A., Westermark, P., and Steiner, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Leckstrom,"

Phrase: "A.,"

Phrase: "Westermark,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Steiner,"

Phrase: "D."
Processing 00000000.tx.330: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.331: (1993) FEBS Lett. 

Phrase: "(1993"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.332: 323, 40-44[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "323,"

Phrase: "40-44"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.333: D'Alessio, D. 

Phrase: "D'"

Phrase: "Alessio,"

Phrase: "D."
Processing 00000000.tx.334: A., Verchere, C. 

Phrase: "A.,"

Phrase: "Verchere,"

Phrase: "C."
Processing 00000000.tx.335: B., Kahn, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kahn,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.336: E., Hoagland, V., Baskin, D. 

Phrase: "E.,"

Phrase: "Hoagland,"

Phrase: "V.,"

Phrase: "Baskin,"

Phrase: "D."
Processing 00000000.tx.337: G., Palmiter, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Palmiter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: D., and Ensinck, J. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Ensinck,"

Phrase: "J."
Processing 00000000.tx.339: W. 

Phrase: "W."
Processing 00000000.tx.340: (1994) Diabetes 43, 1457-1461[Abstract] 22. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Diabetes 43,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "1457-1461"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 22."
Processing 00000000.tx.341: Westermark, P., Engstrom, U., Johnson, K. 

Phrase: "Westermark,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Engstrom,"

Phrase: "U.,"

Phrase: "Johnson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.342: H., Westermark, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Westermark,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.343: T., and Betsholtz, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Betsholtz,"

Phrase: "C."
Processing 00000000.tx.344: (1990) Proc. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.345: Natl. 

Phrase: "Natl."
Processing 00000000.tx.346: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.347: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.348: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.349: 87, 5036-5040[Abstract] 23. 

Phrase: "87,"

Phrase: "5036-5040"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.350: Bhathena, S. 

Phrase: "Bhathena,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.351: J., Timmers, K. 

Phrase: "J.,"

Phrase: "Timmers,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.352: I., Oie, H. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Oie,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.353: K., Voyles, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Voyles,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.354: R., and Recant, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Recant"

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.355: (1985) Diabetes 34, 121-128[Abstract] 24. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Diabetes 34,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "121-128"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24."
Processing 00000000.tx.356: Bennett, R. 

Phrase: "Bennett,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.357: G., Hamel, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hamel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.358: G., and Duckworth, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.359: C. 

Phrase: "C."
Processing 00000000.tx.360: (2000) The Endocrine Society's 82nd Annual Meeting , p. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The Endocrine Society's 82nd Annual Meeting ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0556656:Meeting [Health Care Activity]

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.361: 89, The Endocrine Society, Toronto, Canada Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "89,"

Phrase: "The Endocrine Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "Toronto,"

Phrase: "Canada Copyright  2000 by The American Society"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0006823:Canada [Geographic Area]
   748   C0009993:Copyright [Intellectual Product]
   748   C0037455:society [Organization]
   748   C0596070:American [Population Group]
   748   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

